684 related articles for article (PubMed ID: 32978516)
1. Aberrant NSUN2-mediated m
Sun Z; Xue S; Zhang M; Xu H; Hu X; Chen S; Liu Y; Guo M; Cui H
Oncogene; 2020 Nov; 39(45):6906-6919. PubMed ID: 32978516
[TBL] [Abstract][Full Text] [Related]
2. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
3. A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53.
Mao C; Wang X; Liu Y; Wang M; Yan B; Jiang Y; Shi Y; Shen Y; Liu X; Lai W; Yang R; Xiao D; Cheng Y; Liu S; Zhou H; Cao Y; Yu W; Muegge K; Yu H; Tao Y
Cancer Res; 2018 Jul; 78(13):3484-3496. PubMed ID: 29588351
[TBL] [Abstract][Full Text] [Related]
4. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma.
Ye Y; Guo J; Xiao P; Ning J; Zhang R; Liu P; Yu W; Xu L; Zhao Y; Yu J
Cancer Lett; 2020 Jan; 469():310-322. PubMed ID: 31705929
[TBL] [Abstract][Full Text] [Related]
5. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
Song Y; Xing H; Zhou L; Zhang N; Yang M
Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
[TBL] [Abstract][Full Text] [Related]
6. A novel lncRNA PLK4 up-regulated by talazoparib represses hepatocellular carcinoma progression by promoting YAP-mediated cell senescence.
Jia Y; Jin H; Gao L; Yang X; Wang F; Ding H; Chen A; Tan S; Zhang F; Shao J; Wang S; Zheng S
J Cell Mol Med; 2020 May; 24(9):5304-5316. PubMed ID: 32243714
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
[TBL] [Abstract][Full Text] [Related]
8. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
[TBL] [Abstract][Full Text] [Related]
9. RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy-related-1 in vitro and in vivo.
Zhai CT; Tian YC; Tang ZX; Shao LJ
Kaohsiung J Med Sci; 2021 Nov; 37(11):991-999. PubMed ID: 34370374
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
11. Galangin promotes cell apoptosis through suppression of H19 expression in hepatocellular carcinoma cells.
Zhong X; Huang S; Liu D; Jiang Z; Jin Q; Li C; Da L; Yao Q; Wang D
Cancer Med; 2020 Aug; 9(15):5546-5557. PubMed ID: 32485786
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma.
Rojas Á; Gil-Gómez A; de la Cruz-Ojeda P; Muñoz-Hernández R; Sánchez-Torrijos Y; Gallego-Durán R; Millán R; Rico MC; Montero-Vallejo R; Gato-Zambrano S; Maya-Miles D; Ferrer MT; Muntané J; Robles-Frías MJ; Ampuero J; Padillo FJ; Romero-Gómez M
Liver Int; 2022 Jun; 42(6):1410-1422. PubMed ID: 35243752
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma.
Yuan SX; Zhang J; Xu QG; Yang Y; Zhou WP
Cancer Lett; 2016 Sep; 379(2):239-44. PubMed ID: 26282784
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
Zhou Y; Fan RG; Qin CL; Jia J; Wu XD; Zha WZ
Genomics; 2019 Dec; 111(6):1862-1872. PubMed ID: 30543848
[TBL] [Abstract][Full Text] [Related]
17. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
[TBL] [Abstract][Full Text] [Related]
18. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA
Pan W; Zhang N; Liu W; Liu J; Zhou L; Liu Y; Yang M
J Biol Chem; 2018 Nov; 293(44):17154-17165. PubMed ID: 30228180
[TBL] [Abstract][Full Text] [Related]
20. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
